GLP-1 Savings Cards: Are They Worth It? A Complete Breakdown
Prices verified May 22, 2026 · Updated for 2026
Manufacturer savings cards can reduce GLP-1 costs to $25/month or less with qualifying commercial insurance—unbeatable when you're eligible. The catch: they exclude Medicare, Medicaid, and government insurance; they expire (typically 12–24 months); and they don't help if your insurer doesn't cover GLP-1s at all. If you have commercial insurance with GLP-1 coverage, savings cards are a no-brainer. If you don't, compounded alternatives at $99–$299/mo are your best path.
What savings cards actually are
Manufacturer savings cards (also called copay cards or copay assistance) are programs from Novo Nordisk and Eli Lilly that reduce your out-of-pocket cost for brand-name GLP-1 medications. They're not insurance—they're manufacturer-funded discounts that bridge the gap between what your insurance covers and what you'd otherwise owe.
Both major GLP-1 manufacturers offer them, and when you qualify, they can make brand-name medications cheaper than compounded alternatives.
How they work, step by step
- Your doctor prescribes a brand-name GLP-1 (Wegovy, Zepbound, etc.)
- Your insurance processes the claim and determines your copay/coinsurance
- The savings card reduces your out-of-pocket portion to a set amount ($0–$25/mo in most cases)
- The manufacturer pays the difference directly to the pharmacy
Current savings card programs (May 2026)
| Manufacturer | Medications | With insurance coverage | Without insurance coverage | Exclusions |
|---|---|---|---|---|
| Novo Nordisk | Wegovy, Ozempic, Rybelsus | As low as $25/mo | Not eligible for savings card (use NovoCare cash-pay instead) | Medicare, Medicaid, Tricare, government plans |
| Eli Lilly | Zepbound, Mounjaro, Foundayo | As low as $25/mo | $550/mo for Zepbound (without any insurance) | Medicare, Medicaid, government plans |
When savings cards save you the most
- Best case: You have commercial insurance that covers GLP-1s for weight loss. Your copay drops to $25/mo. 12-month cost: $300. This is unbeatable.
- Good case: Your insurance covers the medication for diabetes (Ozempic, Mounjaro) even if not for weight loss. Savings card applies to the covered medication.
- Moderate case: Eli Lilly's no-insurance savings card for Zepbound at $550/mo—better than list price ($1,059) but far more expensive than compounded ($133–$399).
When savings cards don't help
- Medicare/Medicaid recipients: Savings cards are legally prohibited for government insurance programs. The Medicare GLP-1 Bridge ($50/mo starting July 2026) is your alternative.
- No insurance at all: Novo Nordisk doesn't offer a savings card for uninsured patients (NovoCare cash-pay at $149–$349/mo is the alternative). Eli Lilly offers $550/mo for Zepbound without insurance—which is rarely the best option.
- Insurance that excludes GLP-1s for weight loss: If your plan doesn't cover the medication at all, the savings card has nothing to reduce. You're effectively uninsured for this medication.
- After expiration: Most savings cards have 12–24 month limits or annual caps. When they expire, your cost reverts to the full copay/coinsurance amount.
The math: savings card vs. compounded
| Scenario | Savings card cost | Compounded cost | Winner |
|---|---|---|---|
| Commercial insurance covers GLP-1 | $25/mo | $99–$299/mo | Savings card |
| Insurance doesn't cover GLP-1 | N/A (Novo) / $550 (Lilly) | $99–$299/mo | Compounded |
| Medicare (before July 2026) | Not eligible | $99–$299/mo | Compounded |
| Medicare (after July 2026) | N/A (use Bridge at $50/mo) | $99–$299/mo | Medicare Bridge |
| After savings card expires | Full copay ($200–$600+) | $99–$299/mo | Depends on copay |
Our recommendation
Step 1: Check if your insurance covers GLP-1s for weight loss. If yes, apply for the manufacturer savings card immediately—$25/mo is unbeatable. Step 2: If your insurance doesn't cover it, skip the savings card path entirely and go directly to compounded GLP-1s through a verified provider ($99–$299/mo). Step 3: If you're on Medicare, wait for the Bridge (July 2026) or use compounded until then.
🏥 Compare by Insurance Status
Compounded medications are not FDA-approved. Consult a licensed provider to determine if treatment is appropriate for you.
Sesame Care
Access to FDA-approved brand-name GLP-1 medications through licensed providers.
Get StartedEmbody
Compounded semaglutide with metabolic report, 1:1 guidance, and personalized plan.
Start for $149GobyMeds
LegitScript-verified. Semaglutide & tirzepatide bundles, free consult, free shipping.
Get StartedYucca Health
Budget-friendly compounded semaglutide and tirzepatide with multi-month discounts.
See PlansSources & References
- Novo Nordisk savings card program terms, verified May 2026.
- Eli Lilly savings card program terms, verified May 2026.
- CMS: Medicare GLP-1 Bridge program details, 2026.
- FTC: Guidance on manufacturer copay assistance programs.